Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05027282 · ClinicalTrials.gov registry record · NA
Safety and Effectiveness of the CLEAR + BRILLIANT TOUCH(R) Diode Laser 1440-nm and 1927-nm Combination Wavelength Treatment
A NA study of Photoaging, sponsored by Bausch Health Americas.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
- 1
- Study location
NCT05027282 is a NA study of Photoaging that has completed, run by Bausch Health Americas. The registered enrollment target is 28 participants, roughly in line with the 30-participant average among 14 other Photoaging trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT05027282, a NA study of Photoaging, has completed, sponsored by Bausch Health Americas.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective study of up to 30 subjects designed to assess the safety and effectiveness of a non-ablative fractional laser combination wavelength treatment for general resurfacing of photoaged skin. All study subjects will be treated on the whole face with the CLEAR + BRILLIANT TOUCH(R) 1440-nm and 1927-nm handpieces. Subjects will be treated with a consecutive series of four (4) treatments spaced 1 month apart, along with follow-up study visits at one (1) and three (3) months after final treatment.
Conditions Studied
Interventions
- DEVICE CLEAR + BRILLIANT TOUCH(R) 1440-nm and 1927-nm handpieces.
Study Locations (1)
Texas
- Bausch Site 001 - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2021-10-27 |
| Est. Completion | 2022-11-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05027282
The ClinicalTrials.gov registry entry for NCT05027282 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 30-participant average among 14 other Photoaging trials with a reported enrollment target. The listed sponsor is Bausch Health Americas, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Photoaging appearing as the primary indexed condition, and to 1 intervention - of which CLEAR + BRILLIANT TOUCH(R) 1440-nm and 1927-nm handpieces. is the first listed.
NCT05027282 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT05027282 about?
NCT05027282 is a clinical study titled "Safety and Effectiveness of the CLEAR + BRILLIANT TOUCH(R) Diode Laser 1440-nm and 1927-nm Combination Wavelength Treatment". This is a prospective study of up to 30 subjects designed to assess the safety and effectiveness of a non-ablative fractional laser combination wavelength treatment for general resurfacing of photoaged skin. All study subjects will be treated on the whole face with the CLEAR + BRILLIANT TOUCH(R) 144...
What is the current status of trial NCT05027282?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2021-10-27. Estimated completion is 2022-11-18.
What conditions does trial NCT05027282 study?
This clinical trial studies the following conditions: Photoaging.
What interventions are being tested in trial NCT05027282?
The interventions under investigation include: CLEAR + BRILLIANT TOUCH(R) 1440-nm and 1927-nm handpieces. (DEVICE).
Who is sponsoring clinical trial NCT05027282?
This trial is sponsored by Bausch Health Americas, which has 168 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05027282 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Photoaging
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Investigating Age Dependence of Fibroblast and Extracellular Matrix Responses to Cross-linked Hyaluronic Acid Filler in Human Skin
RECRUITING · NA
-
Evaluation of the Effects of a Biostimulator and Dermal Fillers for Cheek Augmentation and Contour Deficiencies
ACTIVE NOT RECRUITING · NA
-
Evaluating Procedure Pairing of a Post-Procedure Cream Versus a Comparator in Patients Treated With a Radiofrequency Microneedling for Facial Rejuvenation
COMPLETED · NA
-
Double-Blind Study Determining the Efficacy of CannaXR in Decreasing UVA Premutagenic and Photoaging Markers
COMPLETED · NA
-
A Clinical Study to Evaluate Efficacy and Safety of a Cosmetic Product in the Treatment of Facial Lines
COMPLETED · NA
-
An Exploratory Investigation of a Novel Skincare Regimen
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.